Vivien Yin, PhD

  • 224 Citations
  • 9 Scopus h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Vivien Yin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Hand Hygiene Medicine & Life Sciences
Toxicity Mathematics
Dose Finding Mathematics
Neoplasms Medicine & Life Sciences
Skilled Nursing Facilities Medicine & Life Sciences
Maximum Tolerated Dose Medicine & Life Sciences
Subacute Care Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2019

  • 224 Citations
  • 9 Scopus h-Index
  • 21 Article
  • 1 Review article

A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma

Xie, H., Yin, J., Shah, M. H., Menefee, M. E., Bible, K. C., Reidy-Lagunes, D., Kane, M. A., Quinn, D. I., Gandara, D. R., Erlichman, C. & Adjei, A., Jan 1 2019, In : Investigational New Drugs.

Research output: Contribution to journalArticle

Adrenocortical Carcinoma
B-Cell Lymphoma

Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia

Ruppert, A. S., Yin, J., Davidian, M., Tsiatis, A. A., Byrd, J. C., Woyach, J. A. & Mandrekar, S. J., Apr 1 2019, In : Annals of oncology : official journal of the European Society for Medical Oncology. 30, 4, p. 542-550 9 p.

Research output: Contribution to journalArticle

Open Access
B-Cell Chronic Lymphocytic Leukemia
PCI 32765
Residual Neoplasm
Sample Size

Challenges encountered and lessons learned during a trial of an electronic hand hygiene monitoring system

Boyce, J. M., Cooper, T., Yin, J., Li, F. Y. & Arbogast, J. W., Jan 1 2019, In : American journal of infection control.

Research output: Contribution to journalArticle

Hand Hygiene
Patients' Rooms
Critical Care
Intensive Care Units
1 Citation (Scopus)

Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)

Yin, J., Laplant, B., Uy, G. L., Marcucci, G., Blum, W., Larson, R. A., Stone, R. M. & Mandrekar, S. J., Jun 11 2019, In : Blood Advances. 3, 11, p. 1714-1721 8 p.

Research output: Contribution to journalArticle

Open Access
Acute Myeloid Leukemia
Disease-Free Survival
Cell Transplantation
Random Allocation
Endpoint Determination
3 Citations (Scopus)
Phase I Trial
End point